Filter
7231
Filtered Results: 7231
Text search:
health
indicators
Featured
Recommendations
533
New Publications
2123
Language
Document type
No document type
4350
Studies & Reports
1267
Guidelines
703
Manuals
329
Strategic & Response Plan
288
Fact sheets
106
Training Material
69
Situation Updates
57
Resource Platforms
25
Infographics
24
Brochures
6
Online Courses
5
Dashboards/Maps
2
Countries / Regions
India
307
Global
290
Kenya
242
Ethiopia
194
Nepal
186
Uganda
161
Latin America and the Carribbean
158
Sierra Leone
142
Malawi
138
Nigeria
134
Tanzania
129
Liberia
128
Rwanda
127
South Africa
123
Zambia
116
Myanmar / Burma
116
Western and Central Europe
112
Bangladesh
109
Indonesia
100
Ghana
99
Africa
88
Syria
75
Namibia
74
Congo, Democratic Republic of
71
Philippines
66
Ukraine
66
Zimbabwe
60
Lesotho
60
Cambodia
55
Senegal
54
Eastern Europe
50
South–East Asia Region
46
Burkina Faso
45
Mozambique
44
South Sudan
43
Asia
42
Brazil
40
Paraguay
37
Colombia
36
Venezuela
35
Guinea
34
Botswana
33
Cameroon
31
Pakistan
30
East and Southern Africa
30
West and Central Africa
30
Haiti
29
Eswatini/ Swaziland
27
Yemen
26
Russia
26
Middle East and North Africa
23
Benin
21
Peru
21
Eastern Europe and Central Asia
20
Afghanistan
18
Lebanon
18
Sudan
17
Jordan
16
Germany
16
Thailand
16
Central African Republic
16
Argentina
16
Somalia
14
Chile
13
Moldova
12
Mali
11
Vietnam
11
Iraq
10
China
10
Bolivia
10
Madagascar
10
Western Pacific Region
10
Albania
10
Georgia
10
Angola
9
Tajikistan
9
Côte d’Ivoire / Ivory Coast
8
Ecuador
8
Sri Lanka
8
Laos
8
USA
7
Egypt
7
Mexico
7
Niger
6
Turkey
6
North Macedonia
6
El Salvador
6
Iran
6
Togo
5
Chad
5
Papua New Guinea
5
Burundi
5
Palestine
5
Timor Leste/ East Timor
5
Kyrgyzstan
5
North America
5
Saudi Arabia
4
Hungary
4
Honduras
4
Libya
4
Bhutan
4
Poland
4
Armenia
4
Southern Africa
4
Turkmenistan
4
Guinea-Bissau
3
Morocco
3
Gambia
3
Singapore
3
Serbia
3
Greece
3
Guatemala
3
Qatar
3
Romania
3
Kazakhstan
3
Jamaica
3
Portugal
3
Spain
3
Dominican Republic
2
Italy
2
Mongolia
2
Bulgaria
2
Estonia
2
Slovakia
2
Japan
2
France
2
Mauritius
2
Tunisia
2
United Kingdom
2
Azerbaijan
2
Belarus
2
Malaysia
1
Mauritania
1
Ireland
1
Vanuatu
1
Switzerland
1
Croatia
1
Nicaragua
1
Other region
1
Fiji
1
North Korea
1
Djibouti
1
Congo-Brazzaville
1
Canada
1
Lithuania
1
Gabon
1
Uruguay
1
Belgium
1
Maldives
1
Norway
1
Israel
1
Bosnia and Herzegovina
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
3245
Clinical Guidelines
433
Key Resources
386
Public Health
376
Women & Child Health
358
Capacity Building
106
Pharmacy & Technologies
67
Toolboxes
HIV
510
Mental Health
422
TB
389
COVID-19
389
Planetary Health
318
Disability
271
AMR
215
Conflict
188
Caregiver
175
Rapid Response
163
Global Health Education
145
NTDs
137
Ebola
121
NCDs
109
Pharmacy
93
Refugee
92
Natural Hazards
76
Health Financing Toolbox
72
Polio
51
Cholera
36
Zika
28
Specific Hazards
27
Social Ethics
16
Typhoon
5
South Sudan
2
Health Financing
1
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundament...
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de...
Sound periodic programme reviews provide opportunities for countries to objectively assess progress and take corrective action to sustain or get back on track towards achieving their medium and long-term programme goals. It reflects people’s diverse needs, enables efficient use of ... system resources and improves the predictability, sustainability and transparency of the programmes.
This publication provides guidance to countries on how to perform programme reviews for HIV, viral hepatitis and sexually transmitted infections in this dynamic health sector context. The guidance encourages integrated reviews across health programmes for more efficient use of health system resources. The welfare of populations to be served must be at the centre of health programme reviews, with the overarching resolve to protect and promote health as a human right.
This guidance is intended for use by all national partners, including health ministries, related ministries, civil society, affected communities and other stakeholders, for participatory and evidence-informed programme reviews.
This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
The ERF provides WHO staff with essential guidance on how the Organization manages the assessment, grading and response to public health events and emergencies with health consequences, in support o...
Anaemia is a serious global public health problem that particularly affects young children, menstruating adolescent girls and women, and pregnant and postpartum women. It is a condition in which the number of red blood cells or the haemoglobin conce...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public ... problem, one of four priority noncommunicable diseases (NCDs) targeted for action by world leaders. Both the number of cases and the prevalence of diabetes have been steadily increasing over the past few decades.
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is ...
Diabetes mellitus is one of the most common noncommunicable diseases worldwide. In the Eastern Mediterranean Region there has been a rapid increase in the incidence of diabetes mellitus and it is now the fourth leading cause of death. The increasing prevalence of diabetes mellitus, the emergence of ...
The Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020 by the World Health Organization (WHO) outlines a comprehensive strategy to address the global rise in noncommunicable diseases (NCDs), including cardiovascu...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World ... Organization (WHO) call to action by putting into place best-practice TFA policies. Mandatory TFA policies are currently in effect for 3.4 billion people in 60 countries (43% of the world population); of these, 43 countries have best-practice policies in effect, covering 2.8 billion people (36% of the world population).
Over the past year, several additional countries took action to eliminate industrially produced TFA: best-practice policies came into effect in India in January 2022, Uruguay in May 2022 and Oman in July 2022. Best-practice policies were passed in Bangladesh in November 2021 (to come into effect in December 2022) and in Ukraine in September 2020 (to come into effect in October 2023), best-practice TFA policies are projected to pass soon in Mexico, Nigeria and Sri Lanka.
Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks, eliminating human-to-human transmission of the di...
This toolkit is a "how to" guide for developing, implementing and evaluating a multisectoral action plan for prevention and control of NCDs. It is targeted at policy-makers, planners and programme managers, and is intended to help countries, provinces and cities meet the requirements for achieving g...
This toolkit is a "how to" guide for developing, implementing and evaluating a multisectoral action plan for prevention and control of NCDs. It is targeted at policy-makers, planners and programme managers, and is intended to help countries, provinces and cities meet the requirements for achieving g...
The "Assessing National Capacity for the Prevention and Control of Noncommunicable Diseases: Report of the 2021 Global Survey" by WHO examines the global state of readiness and infrastructure for managing noncommunicable diseases (NCDs) across countries. Based on the 2021 survey, it analyzes nationa...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The Implementation toolkit for accessible telehealth services provides practical guidance to support governments, industry partners, health service providers and civil society groups in the use and implementation of the WHO-ITU Global standard for a...
